No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 2.9x · 10Y median 2.9x · 51st percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 28
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T19:13:42.800Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T19:13:42.800Z. Latest historical point 2025-02-06.
EV/EBITDA and cash-flow multiples are withheld until their applicability to this financial-services business is verified. The lenses that apply are shown above; see also P/B and ROE.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T19:13:42.800Z. Latest historical point 2025-02-06.
EBITDA and cash-flow yields are withheld until their applicability to this financial-services business is verified. Earnings yield is shown above; see also P/B and ROE.
The latest delayed quote for StepStone Group Inc. (STEP) stock was $45.06 as of Oct 6, 2026, 3:10 PM EDT, down 2.21% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -28.6% · 3-year avg +18.0%/yr · 5-year avg +5.3%/yr
StepStone Group Inc. is a private equity and venture capital firm specializing in primary, direct, fund of funds, secondary direct, and secondary indirect investments.
Asset Management · New York, NY
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
Nov 5, 2026
30 days away
EPS Estimate
0.57
Revenue Est.
$331.16M
Last Quarter Results
EPS
$0.48
vs Estimate
$0.50
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1STEP | $5.82B | $45.06 | -2.21% | -28.64% | +5.29% | N/A | N/A |
| 2MKTX | $5.77B | $164.09 | +0.03% | -1.89% | -16.50% | +1.17% | vs STEP |
| 3HWC | $5.92B | $72.95 | -0.31% | +20.37% | +11.40% | +11.24% | vs STEP |
| 4BGC | $5.68B | $11.99 | -1.73% | +33.36% | +18.44% | +11.72% | vs STEP |
| 5CACC | $5.61B | $536.03 | +0.88% | +9.32% | -2.87% | +10.68% | vs STEP |
| 6VLYPO | $5.39B | $24.80 | N/A | +6.61% | +8.07% | N/A | vs STEP |
N/A
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$300.60M
vs Estimate
$309.32M
Consensus Rating
Based on 10 analysts
Average Price Target
$67.60
+50.0% upside
Low
$55.00
Current
$45.06
High
$88.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $0.53 | $0.57 | $0.61 | 5 |
| Quarter ending Dec 2026 | $0.70 | $0.79 | $0.90 | 5 |
| Quarter ending Mar 2027 | $0.54 | $0.64 | $0.73 | 3 |
| Quarter ending Jun 2027 | $0.54 | $0.63 | $0.72 | 3 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $2.38 | $2.47 | $2.57 | 6 |
| FY 2028 | $3.31 | $3.38 | $3.43 | 6 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $315.48M | $331.16M | $349.42M | 2 |
| Quarter ending Dec 2026 | $580.82M | $609.73M | $630.05M | 2 |
| Quarter ending Mar 2027 | $326.35M | $370.15M | $411.22M | 1 |
| Quarter ending Jun 2027 | $339.13M | $384.63M | $427.32M | 1 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Mar 31, 2027, matching Key Metrics.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2027 | $1.51B | $1.53B | $1.55B | 4 |
| FY 2028 | $1.73B | $1.81B | $1.87B | 4 |
